These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation. Pärsson H; Holmberg A; Siegbahn A; Bergqvist D Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902 [TBL] [Abstract][Full Text] [Related]
4. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia]. Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb. Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329 [TBL] [Abstract][Full Text] [Related]
7. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 levels and activity decrease after intervention in patients with critical limb ischaemia. Björck M; Lepkowska Eriksson M; Bylock A; Steuer J; Wanhainen A; Carlsson BC; Bock D; Kragsterman B Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):214-22. PubMed ID: 23770264 [TBL] [Abstract][Full Text] [Related]
9. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy]. Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811 [TBL] [Abstract][Full Text] [Related]
10. Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma. Semeraro N; Montemurro P; Giordano P; Santoro N; De Mattia D; Colucci M Thromb Haemost; 1994 Jul; 72(1):54-7. PubMed ID: 7974375 [TBL] [Abstract][Full Text] [Related]
11. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Ruiz-Salmeron R; de la Cuesta-Diaz A; Constantino-Bermejo M; Pérez-Camacho I; Marcos-Sánchez F; Hmadcha A; Soria B Cell Transplant; 2011; 20(10):1629-39. PubMed ID: 22289660 [TBL] [Abstract][Full Text] [Related]
12. Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection. Colucci M; Rossiello MR; Pentimone A; Berloco P; Russo F; Di Leo A; Semeraro N Thromb Res; 2005; 116(6):471-7. PubMed ID: 16181982 [TBL] [Abstract][Full Text] [Related]
13. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia. Gu YQ; Zhang J; Guo LR; Qi LX; Zhang SW; Xu J; Li JX; Luo T; Ji BX; Li XF; Yu HX; Cui SJ; Wang ZG Chin Med J (Engl); 2008 Jun; 121(11):963-7. PubMed ID: 18706241 [TBL] [Abstract][Full Text] [Related]
14. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147 [TBL] [Abstract][Full Text] [Related]
15. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
17. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia. Klepanec A; Mistrik M; Altaner C; Valachovicova M; Olejarova I; Slysko R; Balazs T; Urlandova T; Hladikova D; Liska B; Tomka J; Vulev I; Madaric J Cell Transplant; 2012; 21(9):1909-18. PubMed ID: 22472173 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia. Madaric J; Klepanec A; Valachovicova M; Mistrik M; Bucova M; Olejarova I; Necpal R; Madaricova T; Paulis L; Vulev I Stem Cell Res Ther; 2016 Aug; 7(1):116. PubMed ID: 27530339 [TBL] [Abstract][Full Text] [Related]
19. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment. Dubsky M; Jirkovska A; Bem R; Fejfarova V; Pagacova L; Sixta B; Varga M; Langkramer S; Sykova E; Jude EB Diabetes Metab Res Rev; 2013 Jul; 29(5):369-76. PubMed ID: 23390092 [TBL] [Abstract][Full Text] [Related]
20. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]